AiCure has picked up series C capital from investors such as Singtel Innov8 and Asahi Kasei to bolster its commercial, engineering and R&D efforts.
Author: Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Wrench extracts $20m series C
Wrench operates a mobile vehicle repair service and has added $20m to its coffers thanks to commitment from the likes of Marubeni.
AstraZeneca institutes $1bn fund
AstraZeneca has partnered CICC to launch a fund that will invest in Chinese startups exploiting technologies such as artificial intelligence to improve healthcare.
Freee to figure out IPO
Freee has submitted paperwork for approval to list on the TSE Mothers Market next month, potentially offering exits to more than half a dozen corporates such as Line and Sharp.
Reonomy retrieves $60m series D
Citi Ventures and Wells Fargo Strategic Capital have taken part in a $60m series D round for Reonomy, nearly doubling the proptech developer’s total equity to $128m.
IAN closes $53m fund
Indian Angel Network has achieved a final close of $53m for its inaugural fund thanks to limited partners including Hyundai, Max Group, India Infoline and Yes Bank.
Eight Sleep relaxes with $40m series C
Comcast-backed smart mattress manufacturer Eight Sleep has increased its total funding to almost $65m following a $40m series C round led by Founders Fund.
Human Longevity lengthens funding by $30m
Emerging Technology Partners has returned for a $30m round for HLI, which last closed a $220m series B three years ago backed by Illumina, Celgene and GE.
Riskified takes $165m series E leap
Fidelity has backed a series E round for fraud prevention technology producer Riskified, which last disclosed $33m in series C funding from investors including Capital One in 2017.
HomeLight illuminates $109m
Citi and GV-backed real estate platform HomeLight has collected $63m in a series C round and an additional $46m in debt financing.
Peijia Medical gets series C blood pumping
Lilly Asia Ventures returned for a $100m series C round, after the corporate venturing unit previously also backed a series B round of undisclosed size last year.
A2 Biotherapeutics indexes $57m
Co-founded by Innovative Targeting Solutions, A2 Biotherapeutics has emerged from stealth with $57m in series A financing to develop cell therapies for cancer.
Sila electrifies $45m deal
Canada Pension Plan Investment Board has injected $45m into Sila Nanotechnologies, six months after Daimler led a $170m series E round.
Yikon yields $31m series C
Guangzhou Kingmed has led a $31m series C round for genome sequencing company Yikon Genomics, which was spun out of Harvard University five years ago.